Loading company…
Riskpilot
← Back to search
Sign in
Get full access
APPOTEKET AS
AS
Bankrupt
Org 932059150
Sagaveien 13, 1443 Drøbak
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 5,2M
+237% vs 2023
EBITDA margin
-214.7%
-51494% vs 2023
Equity ratio
-195.0%
Financial strength
Net profit 2024
NOK -13,9M
-81630% vs 2023
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2023
-11M
-1100%
2024
Key figures
Annual report 2024
Revenue
NOK 5,2M
+237%
EBITDA
NOK -11,2M
-51494%
Net profit
NOK -13,9M
-81630%
Total assets
NOK 5,2M
+16%
Equity
NOK -10,1M
-24468%
Employees
0
—
Company information
Legal name
APPOTEKET AS
Org number
932059150
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
12. september 2023
Share capital
NOK 300 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Drift av apotek og nettapotek og det som står i forbindelse med dette, herunder deltakelse i andre selskaper.
Contact
Address
Sagaveien 13, 1443 Drøbak
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Frogn
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
2M
2023
5M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
-11M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
1 550
5 221
Staff expenses
−0
−791
EBITDA
22
−11 210
Depreciation & amort.
−0
−2 000
EBIT
22
−13 210
Net financials
0
−660
Profit before tax
22
−13 870
Tax
5
−0
Net profit
17
−13 870
Balance sheet
NOK thousands
Item
2023
2024
Total assets
4 450
5 180
Equity
41
−10 099
Long-term debt
4 290
14 207
Short-term debt
118
1 071
Total debt
4 408
15 278
Financial ratios
5-year trend
EBITDA margin
-214.7%
This company
15.8%
Market median
-1459% vs market
2023
2024
Equity ratio
-195.0%
This company
38.2%
Market median
-610% vs market
2023
2024
Return on equity
-1386981200.0%
This company
18.4%
Market median
-7537941404% vs market
2023
2024
Net profit margin
-265.6%
This company
8.1%
Market median
-3379% vs market
2023
2024
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
2023
2024
Debt / equity
1.51×
This company
0.62×
Market median
-144% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-08-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
SA
Svein Arne Sørmo
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
KB
Kristian Brekke Djuve
Chairman
2023
—
—
JI
Jens Isak Kobro
Chairman
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
INDIVIDUAL HEALTH SYSTEMS AS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Pharma Clinical Systems As
INDIVIDUAL HEALTH SYSTEMS AS
APPOTEKET AS
(this company)
Board network connections
Board members of APPOTEKET AS also hold positions in
0
other companies.
Person
Role here
Other companies
Svein Arne Sørmo
Chief Executive Officer
0 companies
Kristian Brekke Djuve
Chairman
0 companies
Jens Isak Kobro
Chairman
0 companies